RPg Family Wealth Advisory’s VanEck Pharmaceutical ETF PPH Stock Holding History

RPg Family Wealth Advisory’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,711	Closed	-$599K	–	120
2023 Q1	$599K	Sell	7,711 -3,481	-31%	-$268K	0.33%	55
2022 Q4	$870K	Buy	11,192 +176	+2%	+$13K	0.6%	48
2022 Q3	$779K	Hold	11,016	–	–	0.41%	57
2022 Q2	$846K	Buy	11,016 +3,731	+51%	+$291K	0.5%	47
2022 Q1	$581K	Buy	7,285 +113	+2%	+$8.65K	0.25%	66
2021 Q4	$552K	Buy	7,172 +327	+5%	+$24.3K	0.22%	66
2021 Q3	$498K	Buy	6,845 +198	+3%	+$14.8K	0.21%	80
2021 Q2	$486K	Buy	+6,647	New	+$474K	0.2%	84
2020 Q4	$212K	Buy	+3,184	New	+$204K	0.1%	113

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

VAS

Valicenti Advisory Services Elmira, New York $530M AUM 46.5% 1-Year Est. Return

Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return

RPg Family Wealth Advisory's PPH Position: Q2 2023 in Review

RPg Family Wealth Advisory sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2023, closing a stake of 7,711 shares — an estimated $599K sold.

RPg Family Wealth Advisory first reported a position in PPH in Q4 2020 and held it in 9 quarters. The position peaked at $870K in Q4 2022. 102 funds tracked by Wall St. Rank hold PPH as of Q2 2023.

RPg Family Wealth Advisory reported no remaining VanEck Pharmaceutical ETF position as of Q2 2023 after selling out during the quarter.
RPg Family Wealth Advisory sold 7,711 VanEck Pharmaceutical ETF shares in Q2 2023, an estimated $599K.
RPg Family Wealth Advisory first reported a position in VanEck Pharmaceutical ETF in Q4 2020 and held it in 9 quarters.
RPg Family Wealth Advisory's VanEck Pharmaceutical ETF position peaked at $870K in Q4 2022.
102 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2023.

Based on RPg Family Wealth Advisory's 13F filing for Q2 2023, filed 9 Aug 2023.